Results of a phase 1b clinical trial published in Nature reveal scientists may be one step closer to finding a treatment that safely impedes the biological progression of Alzheimer’s disease.
Although it is established that the incidence of epilepsy is higher among individuals with autoimmune disorders — particularly those that directly affect the brain — a Danish study published in Neurology has specifically linked epilepsy risk among children to whether their mothers have rheumatoid arthritis (RA).
An acid in chicory could reduce impaired memory among people with Alzheimer’s disease and other neurodegenerative disorders, according to research in The FASEB Journal.
Scientists injected mice with lipopolysaccharide (LPS) to induce...
Androgen deprivation therapy (ADT) is a staple of treatment for prostate cancer, but a recent study adds to a growing body of evidence that it places men at higher risk of cognitive decline.
Recent research finds that regardless of the drug selected, physicians should exercise caution when prescribing antipsychotics to Alzheimer’s patients.
With research yielding sometimes discordant findings regarding long-term medical risks of football, physicians are looking for answers for parents concerned about youth participation.
Circadian rhythm disorders, such as irregular sleep-wake rhythms, are hallmarks of Parkinson’s disease. The medical community has traditionally believed the disorders are a side effect of Parkinson’s, but a recently published study is challenging that view.
Arterial stiffness in people as young as their 40s can contribute to Alzheimer’s risk, data from the Framingham Heart Study show.
Researchers are developing a means to quickly dissolve blood clots using a drug-and-device combination that also reduces vascular injury.
The lack of a medication to treat primary-progressive multiple sclerosis (PPMS) is a source of frustration for clinicians and patients. The results of a recent phase 3 study of the drug ocrelizumab may be cause for hope.
- 1 of 5
- next ›